{"id":9666,"date":"2026-01-19T00:16:36","date_gmt":"2026-01-19T00:16:36","guid":{"rendered":"https:\/\/placedesnations.org\/index.php\/2026\/01\/19\/alzheimers-finger-prick-test-could-help-diagnosis\/"},"modified":"2026-01-19T00:16:36","modified_gmt":"2026-01-19T00:16:36","slug":"alzheimers-finger-prick-test-could-help-diagnosis","status":"publish","type":"post","link":"https:\/\/placedesnations.org\/index.php\/2026\/01\/19\/alzheimers-finger-prick-test-could-help-diagnosis\/","title":{"rendered":"Alzheimer&rsquo;s finger-prick test could help diagnosis"},"content":{"rendered":"<p>An international trial is examining whether a finger-prick blood test could be used to help diagnose Alzheimer&rsquo;s disease.<\/p>\n<p>The study, involving 1,000 volunteers aged over 60 in the UK, US and Canada, will aim to detect biomarkers associated with the condition.<\/p>\n<p>Dr Michael Sandberg, a London GP, was encouraged to take part in the study after witnessing his mother&rsquo;s slow decline from Alzheimer&rsquo;s disease. He had a negative result from the tests and said it was \u00ab\u00a0a huge relief\u00a0\u00bb.<\/p>\n<p>The Bio-Hermes-002 study is led by the medical research charity LifeArc and the Global Alzheimer&rsquo;s Platform Foundation, with support from the UK Dementia Research Institute.<\/p>\n<p>Dr Giovanna Lalli, director of strategy and operations at LifeArc, said: \u00ab\u00a0We are looking at the presence of three proteins that have been linked to Alzheimer&rsquo;s disease, so-called blood-based biomarkers.<\/p>\n<p>\u00ab\u00a0By analysing the concentration and the levels of these proteins it may tell us whether a person is at risk of developing Alzheimer&rsquo;s disease.\u00a0\u00bb<\/p>\n<p>Studies have shown that rogue proteins called amyloid and tau can accumulate in the brains of individuals over 15 years before they start to display symptoms of Alzheimer&rsquo;s, the most common form of dementia.<\/p>\n<p>All the volunteers will have the current gold-standard tests for Alzheimer&rsquo;s which involve a specialised brain PET scan using a radioactive tracer, or a lumbar puncture to remove a sample of cerebrospinal fluid.<\/p>\n<p>Such tests are expensive, time-consuming and invasive and only two in 100 Alzheimer&rsquo;s patients are offered them, so the hope is that the finger-prick test could help revolutionise how the disease is identified.<\/p>\n<p>Prof Fiona Carragher, chief policy and research officer at the Alzheimer&rsquo;s Society, said, with tests not currently widely available across the UK, \u00ab\u00a0getting an accurate diagnosis takes far too long\u00a0\u00bb.<\/p>\n<p>She added: \u00ab\u00a0With new treatments on the horizon, early and accurate diagnosis must be a priority for the NHS. That&rsquo;s why we&rsquo;re funding work to bring blood tests for dementia to the NHS, so everyone who would benefit from a diagnosis can get one quickly and accurately.\u00a0\u00bb<\/p>\n<p>Trial participant Sandberg told the BBC: \u00ab\u00a0My mother did very well on a trial and that encouraged me to take part.<\/p>\n<p>\u00ab\u00a0I believe knowledge is power and am really excited that you may be able to screen people at risk of dementia without expensive scans or needles.\u00a0\u00bb<\/p>\n<p>When Sandberg was given his results, both the brain scan and the finger-prick test were negative.  He said: \u00ab\u00a0It&rsquo;s a huge relief, knowing what my mother went through\u00a0\u00bb.<\/p>\n<p>This is &#8211; of course &#8211; just one set of results.  Scientists will need to analyse the findings from all 1,000 volunteers on the trial before they know how useful the finger-prick blood test is at spotting the risk of Alzheimer&rsquo;s.<\/p>\n<p>Dr Emer MacSweeney, a neuro-radiologist at ReCognition Health, is recruiting some of the UK volunteers.<\/p>\n<p>She said: \u00ab\u00a0If this is successful, it provides a ubiquitous, accurate test which can detect the presence of abnormal amyloid protein in the brain without complicated, expensive investigations.\u00a0\u00bb<\/p>\n<p>Using biomarkers in the blood to identify Alzheimer&rsquo;s risk is a rapidly developing field of research.<\/p>\n<p>Last year US regulators approved a blood test for diagnosing Alzheimer&rsquo;s disease. That involves a traditional blood draw using a needle and syringe.<\/p>\n<p>Another study is under way in the UK looking at whether using blood tests improves both the diagnosis and treatment in real-world settings.<\/p>\n<p>A key advantage of the finger-prick test would be that it could be carried out by individuals at home, and the sample be posted to a lab for analysis, as it does not require refrigeration.<\/p>\n<p>There are hopes that blood tests could eventually be used as a screening tool for dementia for older adults.<\/p>\n<p>To date, the study has enrolled 883 of the 1,000 participants with more than 360 completing all the tests.<\/p>\n<p>This includes a mix of cognitively normal and mildly impaired people and some with early-stage Alzheimer&rsquo;s.<\/p>\n<p>At least 25% of volunteers will be from under-represented groups. The trial is expected to complete in 2028.<\/p>\n<p>Get our flagship newsletter with all the headlines you need to start the day. Sign up here.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>An international trial is examining whether a finger-prick blood test could be used to help diagnose Alzheimer&rsquo;s disease. The study, involving 1,000 volunteers aged over 60 in the UK, US and Canada, will aim to detect biomarkers associated with the condition. Dr Michael Sandberg, a London GP, was encouraged to take part in the study [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"post-9666","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-uncategorized"},"_links":{"self":[{"href":"https:\/\/placedesnations.org\/index.php\/wp-json\/wp\/v2\/posts\/9666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/placedesnations.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/placedesnations.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/placedesnations.org\/index.php\/wp-json\/wp\/v2\/comments?post=9666"}],"version-history":[{"count":0,"href":"https:\/\/placedesnations.org\/index.php\/wp-json\/wp\/v2\/posts\/9666\/revisions"}],"wp:attachment":[{"href":"https:\/\/placedesnations.org\/index.php\/wp-json\/wp\/v2\/media?parent=9666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/placedesnations.org\/index.php\/wp-json\/wp\/v2\/categories?post=9666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/placedesnations.org\/index.php\/wp-json\/wp\/v2\/tags?post=9666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}